P
ProQR Therapeutics
0 followers
ProQR Therapeutics develops RNA therapies to potentially transform the lives of patients suffering from inherited retinal diseases.
Org chart
Daniel A. de Boer
Collapse
Gerard Platenburg
Chief Scientific Officer & Co-Founder
Andrew Morris
VP, Business Development
Sheila Sponselee
VP & Head, People & Operations
Sarah Kiely
VP, Investor Relations & Corporate Communications
Bart Klein
Senior VP Innovation
Rene Beukema
Chief Corporate Development Officer & General Counsel
Alise Vilumsone
Executive Assistant To CEO
Board & advisors
Dinko Valerio
Chairman, Supervisory Board
Alison Lawton
Board Member
Bart Filius
Board Member
James Shannon
Board Member
Yi-Tao Yu
Scientific Advisor
Peter Beal
Scientific Advisor
Martin Maier
Scientific Advisor
John Maraganore
Strategic Advisor
Begoña Carreño
Scientific Advisor
Theresa Heggie
Scientific Advisor